-
September 17: The Week in Cancer News
An immunotherapy combination continues to be effective in treating kidney cancer patients, and the FDA approves a therapy for a type of lung cancer.
by Kevin McLaughlin
-
Forward Look
There’s Time to Consider Fertility Preservation OptionsWomen with breast cancer who choose fertility preservation have treatment outcomes similar to women who don't undergo fertility preservation.
by Kris Conner
-
September 10: The Week in Cancer News
9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers
by Marci A. Landsmann
-
Healthy Habits
Mushroom for ImprovementA broad review of existing research finds eating more mushrooms is associated with lower risk of developing cancer.
by Ashley P. Taylor
-
September 3: The Week in Cancer News
Researchers investigate how antibiotics might increase the risk of colon cancer, and the FDA approves a treatment for Waldenström macroglobulinemia.
by Bradley Jones
-
An Emerging Treatment for Metastatic Prostate Cancer
A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
August 27: The Week in Cancer News
Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.
by Bradley Jones
-
August 20: The Week in Cancer News
Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.
by Marci A. Landsmann
-
August 13: The Week in Cancer News
Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.
by Kevin McLaughlin
Cancer Talk
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
